litlas
Log inCreate account

Philippe Rougier

Active 1978–2024

89
Papers
41,024
Citations
84
h-index
89
i10-index

Citations

Citations per year for Philippe Rougier1981: 2 citations1985: 3 citations1986: 8 citations1987: 5 citations1988: 10 citations1989: 2 citations1990: 8 citations1991: 10 citations1992: 9 citations1993: 11 citations1994: 18 citations1995: 19 citations1996: 36 citations1997: 33 citations1998: 60 citations1999: 87 citations2000: 107 citations2001: 109 citations2002: 135 citations2003: 134 citations2004: 153 citations2005: 179 citations2006: 164 citations2007: 188 citations2008: 265 citations2009: 366 citations2010: 453 citations2011: 408 citations2012: 387 citations2013: 355 citations2014: 422 citations2015: 364 citations2016: 342 citations2017: 352 citations2018: 267 citations2019: 983 citations2020: 832 citations2021: 748 citations2022: 464 citations2023: 374 citations2024: 509 citations2025: 247 citations2026: 6 citations1982–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,481 citing papers, 21.4% of this breakdownChina: 912 citing papers, 7.9% of this breakdownItaly: 858 citing papers, 7.4% of this breakdownFrance: 852 citing papers, 7.3% of this breakdownUnited Kingdom: 746 citing papers, 6.4% of this breakdownGermany: 701 citing papers, 6% of this breakdownJapan: 599 citing papers, 5.2% of this breakdownSpain: 449 citing papers, 3.9% of this breakdownNetherlands: 446 citing papers, 3.8% of this breakdownBelgium: 344 citing papers, 3% of this breakdownCanada: 301 citing papers, 2.6% of this breakdownSouth Korea: 279 citing papers, 2.4% of this breakdown
0%21.4%Other 22.7%

Institutions

Fields

  • Medicine79.9%
  • Biochemistry, Genetics and Molecular Biology14.3%
  • Immunology and Microbiology1.4%
  • Materials Science0.9%
  • Computer Science0.6%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Other2.3%

Topics

  • Colorectal Cancer Treatments and Studies12.2%
  • Hepatocellular Carcinoma Treatment and Prognosis6.8%
  • Gastric Cancer Management and Outcomes4.6%
  • Genetic factors in colorectal cancer3.5%
  • Cancer Genomics and Diagnostics3.5%
  • Colorectal Cancer Surgical Treatments3.4%
  • Other66%

Coauthors

All papers

Open in search
  1. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

    Authors: H. Wilke, Kei Muro, Eric Van Cutsem, Sang-Cheul Oh, G. Bodoky, Yasuhiro Shimada, Shuichi Hironaka, Naotoshi Sugimoto, Oleg Lipatov, Tae‐You Kim, David Cunningham, Philippe Rougier, Yoshito Komatsu, Jaffer A. Ajani, Michael Emig, Roberto Carlesi, David Ferry, Kumari Chandrawansa, Jonathan D. Schwartz, Atsushi Ohtsu - The Lancet Oncology 2014 cited by 2,471

  2. Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

    Authors: Eric Van Cutsem, Claus-Henning Köhne, Erika Hitre, J. Załuski, Chung-Rong Chang Chien, Anatoly Makhson, Geert D’Haens, Tamás Pintér, Robert Lim, G. Bodoky, Jae Kyung Roh, Gunnar Folprecht, Paul Ruff, Christopher Stroh, Sabine Tejpar, Michael Schlichting, Johannes Nippgen, Philippe Rougier - New England Journal of Medicine 2009 cited by 3,868

  3. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

    Authors: Bernard Nordlinger, Halfdan Sørbye, Bengt Glimelius, Graeme J. Poston, Peter M. Schlag, Philippe Rougier, Wolf O. Bechstein, John N Primrose, Euan Walpole, Meg Finch-Jones, Daniel Jaeck, Darius Mirza, Rowan W. Parks, Murielle Mauer, E. Tanis, Eric Van Cutsem, Werner Scheithauer, Thomas Gruenberger - The Lancet Oncology 2013 cited by 1,316

  4. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

    Authors: Wendy De Roock, Bart Claes, David Bernasconi, Jef De Schutter, Bart Biesmans, George Fountzilas, Konstantine T. Kalogeras, Vassiliki Kotoula, Demetris Papamichael, Pierre Laurent‐Puig, Frédérique Penault–Llorca, Philippe Rougier, Bruno Vincenzi, Daniele Santini, Giuseppe Tonini, Federico Cappuzzo, Milo Frattini, Francesca Molinari, Piercarlo Saletti, Sara De Dosso, Miriam Martini, Alberto Bardelli, Salvatore Siena, Andrea Sartore‐Bianchi, Josep Tabernero, Teresa Macarulla, Frédéric FIORE, Alice Gangloff, Fortunato Ciardiello, Per Pfeiffer, Camilla Qvortrup, Tine Plato Hansen, Eric Van Cutsem, Hubert Piessevaux, Diether Lambrechts, Mauro Delorenzi, Sabine Tejpar - The Lancet Oncology 2010 cited by 2,143

  5. Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and RAS Mutations in Colorectal Cancer

    Authors: Eric Van Cutsem, Heinz‐Josef Lenz, Claus-Henning Köhne, Volker Heinemann, Sabine Tejpar, I. Melezínek, Frank Beier, Christopher Stroh, Philippe Rougier, J. Han van Krieken, Fortunato Ciardiello - Journal of Clinical Oncology 2015 cited by 800

  6. Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status

    Authors: Eric Van Cutsem, Claus-Henning Köhne, István Láng, Gunnar Folprecht, Marek P. Nowacki, Stefano Cascinu, I. Shchepotin, Joan Maurel, David Cunningham, Sabine Tejpar, Michael Schlichting, Angela Zubel, Ilhan Celik, Philippe Rougier, Fortunato Ciardiello - Journal of Clinical Oncology 2011 cited by 1,887

  7. KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer

    Authors: Astrid Lièvre, Jean‐Baptiste Bachet, Delphine Le Corre, Valérie Boige, Bruno Landi, Jean‐François Emile, Jean‐François Côté, Gorana Tomasic, Christophe Penna, Michel Ducreux, Philippe Rougier, Frédérique Penault‐Llorca, Pierre Laurent‐Puig - Cancer Research 2006 cited by 2,223

  8. Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus

    Authors: René Adam, Aimery de Gramont, Joan Figueras, Norihiro Kokudo, F Kunstlinger, Evelyne M. Loyer, Graeme J. Poston, Philippe Rougier, Laura Rubbia‐Brandt, Alberto Sobrero, Catherine Teh, Sabine Tejpar, Eric Van Cutsem, Jean‐Nicolas Vauthey, Lars Påhlman - Cancer Treatment Reviews 2015 cited by 601

  9. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

    Authors: Bernard Nordlinger, Halfdan Sørbye, Bengt Glimelius, Graeme J. Poston, Peter M. Schlag, Philippe Rougier, Wolf O. Bechstein, John N Primrose, Euan Walpole, Meg Finch-Jones, Daniel Jaeck, Darius Mirza, Rowan W. Parks, Laurence Collette, Michel Praet, Ullrich Bethe, Eric Van Cutsem, Werner Scheithauer, Thomas Gruenberger - The Lancet 2008 cited by 1,945

  10. The Oncosurgery Approach to Managing Liver Metastases from Colorectal Cancer: A Multidisciplinary International Consensus

    Authors: René Adam, Aimery de Gramont, Joan Figueras, Ashley Guthrie, Norihiro Kokudo, F Kunstlinger, Evelyne M. Loyer, Graeme J. Poston, Philippe Rougier, Laura Rubbia‐Brandt, Alberto Sobrero, Josep Tabernero, Catherine Teh, Eric Van Cutsem, Jean-Nicolas Vauthey of the EGOSLIM (Expert Group on OncoSurgery management of LIver Metastases) group - The Oncologist 2012 cited by 594

  11. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

    Authors: Julien Taı̈eb, Josep Tabernero, Enrico Mini, Fabien Subtil, Gunnar Folprecht, Jean-Luc Van Laethem, J. Thaler, John Bridgewater, Lone Nørgård Pétersen, Hélène Blons, Laurence Collette, Eric Van Cutsem, Philippe Rougier, Ramón Salazar, Laurent Bedenne, Jean‐François Emile, Pierre Laurent‐Puig, Côme Lepage - The Lancet Oncology 2014 cited by 284

  12. Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial

    Authors: René Adam, Céline Piedvache, L. Chiche, Jean Philippe Adam, Ephrem Salamé, Petru Bucur, Daniel Cherqui, Olivier Scatton, Victoire Granger, Michel Ducreux, Umberto Cillo, François Cauchy, Jean‐Yves Mabrut, Chris Verslype, Laurent Coubeau, Jean Hardwigsen, Emmanuel Boleslawski, Fabrice Muscari, Heithem Jeddou, Denis Pezet, Bruno Heyd, Valério Lucidi, Karen Geboes, Jan Lerut, Pietro Majno, Lamiae Grimaldi, Françis Lévi, M. Lewin, Maximiliano Gelli, Maximiliano Gelli, René Adam, René Adam, Céline Piedvache, Laurence Chiche, Jean Philippe Adam, Ephrem Salamé, Petru Bucur, Daniel Cherqui, Olivier Scatton, Victoire Granger, Michel Ducreux, Umberto Cillo, François Cauchy, Jean-Yves Mabrut, François Cauchy, Jean-Yves Mabrut, Chris Verslype, Laurent Coubeau, Jean Hardwigsen, Emmanuel Boleslawski, Fabrice Muscari, Heithem Jeddou, Denis Pezet, Bruno Heyd, Valerio Lucidi, Karen Geboes, Jan Lerut, Pietro Majno, Lamiae Grimaldi, Francis Levi, Maïté Lewin, Maximiliano Gelli, Olivier Soubrane, Mickael Lesurtel, Jean Baptsite Bachet, Samuel Lesourd, Marine Jary, Mohamed Bouattour, Sara Lonardi, Mohamed Hebbar, Karim Boudjema, Denis Smith, Mircea Chirica, Thierry Lecomte, Chirstophe Borg, Rosine Guimbaud, Julien Taieb, Patrizia Burra, Philippe Rougier, Joan Figueras - The Lancet 2024 cited by 159

  13. Multicenter Randomized Trial of Adjuvant Fluorouracil and Folinic Acid Compared With Surgery Alone After Resection of Colorectal Liver Metastases: FFCD ACHBTH AURC 9002 Trial

    Authors: G. Portier, Dominique Elias, Olivier Bouché, Philippe Rougier, Jean-François Bosset, Jean Saric, Jacques Belghiti, Pascal Piedbois, Rosine Guimbaud, Bernard Nordlinger, R. Bugat, F Lazorthes, Laurent Bedenne - Journal of Clinical Oncology 2006 cited by 578

  14. Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials

    Authors: Carsten Bokemeyer, Eric Van Cutsem, Philippe Rougier, Fortunato Ciardiello, S. Heeger, Michael Schlichting, Ilhan Celik, Claus‐Henning Köhne - European Journal of Cancer 2012 cited by 593

  15. Prospective, Randomized, Multicenter, Phase III Study of Fluorouracil, Leucovorin, and Irinotecan Versus Epirubicin, Cisplatin, and Capecitabine in Advanced Gastric Adenocarcinoma: A French Intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) Study

    Authors: Rosine Guimbaud, Christophe Louvet, Pauline Ries, Marc Ychou, E. Maillard, Thierry André, Jean‐Marc Gornet, Thomas Aparicio, Suzanne Nguyen, A. Azzedine, Pierre-Luc Etienne, Éveline Boucher, Christine Rebischung, Pascal Hammel, Philippe Rougier, Laurent Bedenne, Olivier Bouché - Journal of Clinical Oncology 2014 cited by 262

  16. KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

    Authors: Astrid Lièvre, Jean‐Baptiste Bachet, Valérie Boige, Anne Cayre, Delphine Le Corre, Emmanuel Buc, Marc Ychou, Olivier Bouché, Bruno Landi, Christophe Louvet, Thierry André, Frédéric Bibeau, Marie-Danièle Diébold, Philippe Rougier, Michel Ducreux, Gorana Tomasic, Jean‐François Emile, Frédérique Penault–Llorca, Pierre Laurent‐Puig - Journal of Clinical Oncology 2008 cited by 1,455

  17. Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study

    Authors: Eric Van Cutsem, Chris Twelves, Jim Cassidy, David Allman, Emilio Bajetta, Michael Boyer, R. Bugat, M Findlay, S. Frings, Michaela K. Jahn, Joe McKendrick, B Osterwalder, G. Pérez-Manga, Riccardo Rosso, Philippe Rougier, Wolff Schmiegel, Jean‐François Seitz, Paul Thompson, José María Viéitez, Christof Weitzel, Peter Harper - Journal of Clinical Oncology 2001 cited by 1,036

  18. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases

    Authors: Eric Van Cutsem, Bernard Nordlinger, René Adam, Claus‐Henning Köhne, Carmelo Pozzo, Graeme J. Poston, Marc Ychou, Philippe Rougier - European Journal of Cancer 2006 cited by 594

  19. Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. Meta-Analysis Group In Cancer.

    Authors: E Lévy, Elliot Levy, P Piedbois, Marc Buyse, Jean‐Pierre Pignon, Philippe Rougier, Louise Ryan, Richard M. Hansen, Benny Zee, Brian Weinerman, J Pater, Cynthia G. Leichman, J Macdonald, Jacqueline Benedetti, J Lokich, J. Fryer, G Brufman, Rut Isacson, A. Laplanche, Emmanuel Quinaux - Journal of Clinical Oncology 1998 cited by 491

  20. Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort

    Authors: Thomas Walter, David Tougeron, Éric Baudin, Karine Le Malicot, Thierry Lecomte, David Malka, Olivia Hentic, Sylvain Manfrédi, Isabelle Bonnet, Rosine Guimbaud, Romain Coriat, Céline Lepère, Christophe Desauw, Anne Thirot‐Bidault, Laëtitia Dahan, Guillaume Roquin, Thomas Aparicio, Jean-Louis Legoux, Catherine Lombard‐Bohas, Jean‐Yves Scoazec, Côme Lepage, Guillaume Cadiot, Laetitia Stephanie, Ivan Borbath, Castex, Caroline Pétorin, Eric Terrebonne, Karine Bouhier‐Leporrier, Etienne Suc, Vincent Hautefeuille, Vincent Bourgeois, Laurent Cany, François Dewaele, Patricia Niccoli, Jean‐François Seitz, Cédric Lecaille, Christine Rebischung, Valérie Rossi, Mathieu Baconnier, Olivier Dubreuil, Marc Ferec, G. Deplanque, Guillaume Geslin, Isabelle Wanicki Caron, S. Lavau Denes, Laurent Bedenne, Catherine Poisson Ligeza, Eric Maringe, Anne-Laure Ran-Royo, J. Guigay, Philippe Rougier - European Journal of Cancer 2017 cited by 112

  21. Influence of Preoperative Chemotherapy on the Risk of Major Hepatectomy for Colorectal Liver Metastases

    Authors: Mehdi Karoui, Christophe Penna, Mohamed Amin-Hashem, Emmanuel Mitry, Stéphane Benoist, Brigitte Franc, Philippe Rougier, Bernard Nordlinger - Annals of Surgery 2005 cited by 720

  22. Complete Response of Colorectal Liver Metastases After Chemotherapy: Does It Mean Cure?

    Authors: Stéphane Benoist, Antoine Brouquet, Christophe Penna, Catherine Julié, Mostafa El Hajjam, S Chagnon, Emmanuel Mitry, Philippe Rougier, Bernard Nordlinger - Journal of Clinical Oncology 2006 cited by 602

  23. Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials

    Authors: Emmanuel Mitry, Anthony Fields, Harry Bleiberg, Roberto Labianca, G. Portier, Dongsheng Tu, Donato Nitti, Valter Torri, Dominique Elias, Chris J. O’Callaghan, Bernard Langer, Giancarlo Martignoni, Olivier Bouché, F Lazorthes, Eric Van Cutsem, Laurent Bedenne, Malcolm J. Moore, Philippe Rougier - Journal of Clinical Oncology 2008 cited by 582

  24. Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer

    Authors: Philippe Rougier, Hanno Riess, Robert Manges, Petr Karásek, Yves Humblet, C. Barone, Armando Santoro, Sylvie Assadourian, Laurence Hatteville, Philip A. Philip - European Journal of Cancer 2013 cited by 180